Craig L Donnelly, MD

Child & Adolescent Psychiatry


  • M.D., University of Vermont, 1985-1989
  • Graduate Science, Non-Degree, University of Vermont, 1984-1985
  • M.A., American University, 1980-1983
  • B.S., Virginia Tech, 1976-1980

Professional Background

Associate Professor of Psychiatry and Pediatrics, Section Chief of Child Psychiatry and Director of Pediatric Psychopharmacology at Dartmouth-Hitchcock Medical Center and Dartmouth Medical School. He has written numerous book chapters and articles on topics in pediatric psychopharmacology and is involved in treatment research across the spectrum of child and adolescent psychiatric disorders including behavioral challenges in those with ASD. He has lectured both nationally and internationally on topics related to pediatric psychopharmacology, the psychopharmacology of stress and trauma treatment, and development of novel systems of care delivery for psychiatric services in youth, both in Europe and the US. He has received extramural funding for numerous clinical trials of different medications in double-blind studies with children and adolescents with disabilities and mental health disorders, including ASD. He moderates the MCHB funded Pediatric Collaborative Office Rounds at CHaD where he provides supervision and child psychiatric consultation to a group of regional pediatricians, pediatric neurologists, and behavioral pediatricians. He worked closely with former Dartmouth faculty Dr. Bryan King to lead the successful STAART ASD research treatment trial.


The NH and ME Leadership in Neurodevelopmental Disabilities Program (NH-ME LEND) is a collaboration among Geisel School of Medicine at Dartmouth, the College of Health and Human Services at the University of New Hampshire, and the Center for Community Inclusion and Disability Studies/UCED at the University of Maine-Orono. The purpose of NH-ME LEND is to improve the health of children and youth with neurodevelopmental disabilities by preparing leaders to enter the field of maternal and child health.